17 – Placental Function in Intrauterine Growth Restriction

[1]  L. Kauvar,et al.  Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. , 2014, The Journal of infectious diseases.

[2]  Jai K. Das,et al.  Impact of intrauterine growth restriction on long-term health , 2014, Current opinion in clinical nutrition and metabolic care.

[3]  D. Peebles,et al.  Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. , 2014, Human gene therapy.

[4]  James M. Roberts,et al.  Pathophysiology of ischemic placental disease. , 2014, Seminars in perinatology.

[5]  B. Huppertz,et al.  Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. , 2014, Journal of reproductive immunology.

[6]  Guoyao Wu,et al.  Down‐regulation of placental mTOR, insulin/IGF‐I signaling, and nutrient transporters in response to maternal nutrient restriction in the baboon , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  K. Thornburg,et al.  Placental programming of chronic diseases, cancer and lifespan: a review. , 2013, Placenta.

[8]  L. Moore,et al.  Graduated effects of high-altitude hypoxia and highland ancestry on birth size , 2013, Pediatric Research.

[9]  K. Thornburg,et al.  The Obstetric Origins of Health for a Lifetime , 2013, Clinical obstetrics and gynecology.

[10]  J. Kingdom,et al.  Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. , 2013, The Cochrane database of systematic reviews.

[11]  A. Ferguson-Smith,et al.  An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  B. Kalionis,et al.  Homeobox genes and down-stream transcription factor PPARγ in normal and pathological human placental development. , 2013, Placenta.

[13]  K. Yoshiura,et al.  Characterization of placenta‐specific microRNAs in fetal growth restriction pregnancy , 2013, Prenatal diagnosis.

[14]  T. Powell,et al.  Review: Adiponectin--the missing link between maternal adiposity, placental transport and fetal growth? , 2013, Placenta.

[15]  K. Joseph,et al.  Fetal growth: a review of terms, concepts and issues relevant to obstetrics , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  Y. Kanai,et al.  Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells , 2013, The Journal of physiology.

[17]  M. Stronati,et al.  Short-term and long-term sequelae in intrauterine growth retardation (IUGR) , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[18]  D. Nicolella,et al.  Baboons as a model to study genetics and epigenetics of human disease. , 2013, ILAR journal.

[19]  T. Powell,et al.  Regulation of Nutrient Transport across the Placenta , 2012, Journal of pregnancy.

[20]  Gynecologists.  Practice Bulletin No. 132: Antiphospholipid syndrome. , 2012, Obstetrics and gynecology.

[21]  D. Goberdhan,et al.  The emerging role of mTORC1 signaling in placental nutrient-sensing. , 2012, Placenta.

[22]  A. Dessì,et al.  Physiopathology of intrauterine growth retardation: from classic data to metabolomics , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[23]  J. Kuller,et al.  Antenatal Surveillance of Fetal Growth Restriction , 2012, Obstetrical & gynecological survey.

[24]  T. Powell,et al.  Placental transport in response to altered maternal nutrition , 2012, Journal of Developmental Origins of Health and Disease.

[25]  M. Glocker,et al.  A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry‐based cord blood serum profiling , 2012, Electrophoresis.

[26]  Lorie M. Harper,et al.  Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[27]  G. Burton,et al.  Review: The placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. , 2012, Placenta.

[28]  Mathew B. Cox,et al.  Evidence of endoplasmic reticulum stress and protein synthesis inhibition in the placenta of non-native women at high altitude , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  S. Ferrara,et al.  Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation , 2011, Electrophoresis.

[30]  S. Apostolidou,et al.  Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. , 2011, International journal of molecular medicine.

[31]  E. Ghigo,et al.  The Intensity of IUGR-Induced Transcriptome Deregulations Is Inversely Correlated with the Onset of Organ Function in a Rat Model , 2011, PloS one.

[32]  Carmen J. Marsit,et al.  miR-16 and miR-21 Expression in the Placenta Is Associated with Fetal Growth , 2011, PloS one.

[33]  I. Brosens,et al.  Defective deep placentation. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[34]  J. Dumoulin,et al.  Epigenetics and the placenta. , 2011, Human reproduction update.

[35]  A. Odibo,et al.  Diagnosis and Management of Fetal Growth Restriction , 2011, Journal of pregnancy.

[36]  A. Gruslin,et al.  Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction , 2011, BJOG : an international journal of obstetrics and gynaecology.

[37]  T. Todros,et al.  Review: Feto-placental vascularization: a multifaceted approach. , 2011, Placenta.

[38]  B. Manning,et al.  mTOR couples cellular nutrient sensing to organismal metabolic homeostasis , 2011, Trends in Endocrinology & Metabolism.

[39]  R. Romero,et al.  The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. , 2011, American journal of obstetrics and gynecology.

[40]  D. Spandidos,et al.  Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[41]  T. Hata,et al.  Three-dimensional ultrasound evaluation of the placenta. , 2011, Placenta.

[42]  Y. Kanai,et al.  Maternal Protein Restriction in the Rat Inhibits Placental Insulin, mTOR, and STAT3 Signaling and Down-Regulates Placental Amino Acid Transporters , 2011, Endocrinology.

[43]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[44]  A. Smerieri,et al.  Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth. , 2011, European journal of endocrinology.

[45]  I. Crocker,et al.  Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast , 2011, Apoptosis.

[46]  I. Crocker,et al.  Placental Apoptosis in Health and Disease , 2010, American journal of reproductive immunology.

[47]  S. Brennecke,et al.  Placental biglycan expression is decreased in human idiopathic fetal growth restriction. , 2010, Placenta.

[48]  R. Chapin,et al.  Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[49]  S. Brennecke,et al.  Decorin expression is decreased in human idiopathic fetal growth restriction. , 2010, Reproduction, fertility, and development.

[50]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[51]  I. Cetin,et al.  Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction , 2010, Epigenetics.

[52]  R. Yuen,et al.  DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia , 2010, European Journal of Human Genetics.

[53]  Majida Abu Shehab,et al.  Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance. , 2010, Journal of proteome research.

[54]  M. Tuuli,et al.  First‐trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction , 2010, Prenatal diagnosis.

[55]  G. Rice,et al.  Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. , 2010, Placenta.

[56]  R. Schild,et al.  Microarray analysis of placental tissue in intrauterine growth restriction , 2010, Clinical endocrinology.

[57]  L. Moore.  The Placenta and Human Developmental Programming: Uterine blood flow as a determinant of fetoplacental development , 2010 .

[58]  D. Charnock-Jones,et al.  The influence of the intrauterine environment on human placental development. , 2010, The International journal of developmental biology.

[59]  T. Marton,et al.  Pathological assessment of intrauterine growth restriction. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[60]  P. Kyle,et al.  Aetiology and pathogenesis of IUGR. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[61]  R. Cruz‐Martínez,et al.  The role of Doppler and placental screening. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[62]  Majida Abu Shehab,et al.  Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction. , 2009, Journal of proteome research.

[63]  T. Powell,et al.  The role of trophoblast nutrient and ion transporters in the development of pregnancy complications and adult disease. , 2009, Current vascular pharmacology.

[64]  C. Marsit,et al.  REVIEW ARTICLE: Epigenetics in the Placenta , 2009, American journal of reproductive immunology.

[65]  I. Crocker,et al.  Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. , 2009, Placenta.

[66]  J. Aplin,et al.  Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. , 2009, The American journal of pathology.

[67]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[68]  Y. Kanai,et al.  Regulation of placental amino acid transporter activity by mammalian target of rapamycin. , 2009, American journal of physiology. Cell physiology.

[69]  I. Crocker,et al.  Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. , 2008, Placenta.

[70]  Wieland Kiess,et al.  IGF signaling defects as causes of growth failure and IUGR , 2008, Trends in Endocrinology & Metabolism.

[71]  D. Charnock-Jones,et al.  Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. , 2008, The American journal of pathology.

[72]  J. Morrison.  SHEEP MODELS OF INTRAUTERINE GROWTH RESTRICTION: FETAL ADAPTATIONS AND CONSEQUENCES , 2008, Clinical and experimental pharmacology & physiology.

[73]  D. Skupski,et al.  Intrauterine restriction (IUGR) , 2008, Journal of perinatal medicine.

[74]  R. Tyson,et al.  The intrauterine growth-restricted fetus and placenta evaluation. , 2008, Seminars in perinatology.

[75]  I. Bernstein,et al.  Optimal growth modeling. , 2008, Seminars in perinatology.

[76]  B. Manning,et al.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.

[77]  R. Lane,et al.  Programmed Upregulation of Adipogenic Transcription Factors in Intrauterine Growth-Restricted Offspring , 2008, Reproductive Sciences.

[78]  Y. Sadovsky,et al.  PPAR Signaling in Placental Development and Function , 2007, PPAR research.

[79]  Jing Xu,et al.  Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. , 2008, The Journal of clinical endocrinology and metabolism.

[80]  Luciano Marcondes Machado Nardozza,et al.  Placenta: angiogenesis and vascular assessment through three-dimensional power Doppler ultrasonography , 2008, Archives of Gynecology and Obstetrics.

[81]  Y. Sadovsky,et al.  Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. , 2007, American journal of obstetrics and gynecology.

[82]  T. Powell,et al.  Mammalian target of rapamycin in the human placenta regulates leucine transport and is down‐regulated in restricted fetal growth , 2007, The Journal of physiology.

[83]  V. V. van Hinsbergh,et al.  Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues. , 2007, Fertility and sterility.

[84]  C. Ananth,et al.  Risk factors for antepartum and intrapartum stillbirth: a population-based study. , 2007, American journal of obstetrics and gynecology.

[85]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[86]  W. Reik.  Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[87]  I. Cetin,et al.  Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. , 2007, American journal of physiology. Endocrinology and metabolism.

[88]  M. Beckmann,et al.  Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. , 2007, Clinical science.

[89]  V. Ganapathy,et al.  Down‐regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet , 2006, The Journal of physiology.

[90]  C. Sibley,et al.  Placental Lactate Transporter Activity and Expression in Intrauterine Growth Restriction , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[91]  R. Weksberg,et al.  Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. , 2006, Placenta.

[92]  D. Maulik.  Fetal growth compromise: definitions, standards, and classification. , 2006, Clinical obstetrics and gynecology.

[93]  D. Maulik.  Fetal growth restriction: the etiology. , 2006, Clinical obstetrics and gynecology.

[94]  Y. Sadovsky,et al.  The pleiotropic function of PPARγ in the placenta , 2006, Molecular and Cellular Endocrinology.

[95]  S Apostolidou,et al.  Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. , 2006, Human molecular genetics.

[96]  M. Senat,et al.  Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. , 2006, American journal of obstetrics and gynecology.

[97]  D. Tollefsen,et al.  Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. , 2006, Blood.

[98]  A. Okamoto,et al.  IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. , 2006, Placenta.

[99]  J. Kingdom,et al.  Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[100]  I. Cetin,et al.  Placental LPL Gene Expression Is Increased in Severe Intrauterine Growth-Restricted Pregnancies , 2006, Pediatric Research.

[101]  I. Sandovici,et al.  Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Michael Lehrke,et al.  The Many Faces of PPARγ , 2005, Cell.

[103]  Thomas Jansson,et al.  Placental Phenotypes of Intrauterine Growth , 2005, Pediatric Research.

[104]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[105]  Pinchas Cohen,et al.  The role of the insulin-like growth factor system in prenatal growth. , 2005, Molecular genetics and metabolism.

[106]  A. Okamoto,et al.  Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms. , 2005, International journal of molecular medicine.

[107]  G. Burton,et al.  Placental morphometry and Doppler flow velocimetry in cases of chronic human fetal hypoxia. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[108]  A. Ferguson-Smith,et al.  Imprinted genes in the placenta--a review. , 2005, Placenta.

[109]  Y. Sadovsky,et al.  Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. , 2005, Placenta.

[110]  R. Giorgino,et al.  Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. , 2005, Endocrinology.

[111]  V. Han,et al.  Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. , 2005, The Journal of endocrinology.

[112]  T. Mayhew,et al.  Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. , 2004, Placenta.

[113]  B. Stray-Pedersen,et al.  Restricted fetal growth in sudden intrauterine unexplained death , 2004, Acta obstetricia et gynecologica Scandinavica.

[114]  E. Jauniaux,et al.  Placental Oxidative Stress: From Miscarriage to Preeclampsia , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[115]  T. Powell,et al.  Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[116]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[117]  A. Correa,et al.  A review of the literature on the effects of ambient air pollution on fetal growth. , 2004, Environmental research.

[118]  A. Romo,et al.  Study of genetic expression of intrauterine growth factors IGF-I and EGFR in placental tissue from pregnancies with intrauterine growth retardation. , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[119]  R. Bahado-Singh,et al.  Fetal Doppler velocimetry. , 2004, Obstetrics and gynecology clinics of North America.

[120]  E. Ferrazzi,et al.  Differences in fat and lean mass proportions in normal and growth-restricted fetuses. , 2003, American journal of obstetrics and gynecology.

[121]  H. Schröder.  Models of fetal growth restriction. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[122]  J. Howell,et al.  A Novel Hypoxia-inducible Factor-independent Hypoxic Response Regulating Mammalian Target of Rapamycin and Its Targets* , 2003, Journal of Biological Chemistry.

[123]  R. Wilkening,et al.  The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction , 2003, The Journal of physiology.

[124]  B. Brenner,et al.  Haemostatic mechanisms in human placenta. , 2003, Best practice & research. Clinical haematology.

[125]  T. Powell,et al.  Activity and protein expression of Na+/K+ ATPase are reduced in microvillous syncytiotrophoblast plasma membranes isolated from pregnancies complicated by intrauterine growth restriction. , 2003, The Journal of clinical endocrinology and metabolism.

[126]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[127]  B. Johansson,et al.  Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. , 2003, The Journal of clinical endocrinology and metabolism.

[128]  P. Baker,et al.  Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. , 2003, Placenta.

[129]  J. Kingdom,et al.  Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. , 2003, Placenta.

[130]  Michael N. Hall,et al.  TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.

[131]  H. Athapathu,et al.  A study of the incidence of apoptosis in the human placental cells in the last weeks of pregnancy , 2003, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[132]  E. Jauniaux,et al.  Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. , 2003, The American journal of pathology.

[133]  C. Sibley,et al.  Activity and protein expression of the Na+/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. , 2002, The Journal of clinical endocrinology and metabolism.

[134]  T. Powell,et al.  Parathyroid hormone-related peptide (38-94) amide stimulates ATP-dependent calcium transport in the Basal plasma membrane of the human syncytiotrophoblast. , 2002, The Journal of endocrinology.

[135]  B. Tycko,et al.  Physiological functions of imprinted genes , 2002, Journal of cellular physiology.

[136]  Chie-Pein Chen,et al.  Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. , 2002, American journal of obstetrics and gynecology.

[137]  C. C. Pillai,et al.  Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.

[138]  R. Simmons,et al.  Placental Expression of Insulin-Like Growth Factor Receptor-1 and Insulin Receptor in the Growth-Restricted Fetal Rat , 2002, The Journal of the Society for Gynecologic Investigation: JSGI.

[139]  D. Charnock-Jones,et al.  Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia , 2002, Circulation research.

[140]  W. Reik,et al.  Placental-specific IGF-II is a major modulator of placental and fetal growth , 2002, Nature.

[141]  Y. Sadovsky,et al.  Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. , 2002, American journal of obstetrics and gynecology.

[142]  T. Powell,et al.  Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. , 2002, Placenta.

[143]  C. Sibley,et al.  Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project 'Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies'-a workshop report. , 2002, Placenta.

[144]  K. Maršál,et al.  Can the degree of retrograde diastolic flow in abnormal umbilical artery flow velocity waveforms predict pregnancy outcome? , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[145]  R. Wilkening,et al.  Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). , 2002, Placenta.

[146]  A. Jaeschke,et al.  Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.

[147]  G. Pardi,et al.  Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. , 2001, The Journal of clinical endocrinology and metabolism.

[148]  K. Marsh,et al.  Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae , 2001, Tropical medicine & international health : TM & IH.

[149]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[150]  Z. Calay,et al.  Apoptosis in the placenta of pregnancies complicated with IUGR , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[151]  F. Petraglia,et al.  Human Placenta as a Source of Neuroendocrine Factors , 2001, Neonatology.

[152]  C. Dalçik,et al.  Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses. , 2001, Acta histochemica.

[153]  N. Kanayama,et al.  Intraplacental Coagulation in Intrauterine Growth Restriction: Cause or Result? , 2001, Seminars in thrombosis and hemostasis.

[154]  W. Reik,et al.  Genomic imprinting: parental influence on the genome , 2001, Nature Reviews Genetics.

[155]  L. Vatten,et al.  Preeclampsia and Fetal Growth , 2000, Obstetrics and gynecology.

[156]  W. Ott.  Intrauterine growth restriction and Doppler ultrasonography. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[157]  B Huppertz,et al.  Development of the placental villous tree and its consequences for fetal growth. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[158]  E. Gilbert-Barness,et al.  Abnormal Umbilical Cord Coiling Is Associated with Adverse Perinatal Outcomes , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[159]  R. Jaffe,et al.  Role of angiopoietins in reproductive tract angiogenesis. , 2000, Obstetrical & gynecological survey.

[160]  B. Bussolati,et al.  Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. , 2000, The American journal of pathology.

[161]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[162]  K. Nicolaides,et al.  The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. , 1999, Human reproduction.

[163]  N. Özdemir,et al.  The Comparison of Uterine Artery Doppler Velocimetry with the Histopathology of the Placental Bed , 1999, The Australian & New Zealand journal of obstetrics & gynaecology.

[164]  J. Kingdom,et al.  Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. , 1999, Obstetrics and gynecology.

[165]  A. N. Corps,et al.  A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. , 1998, Biology of reproduction.

[166]  R. Ohlsson,et al.  The H19 Transcript Is Associated with Polysomes and May Regulate IGF2 Expression intrans* , 1998, The Journal of Biological Chemistry.

[167]  T. Powell,et al.  Placental Transport of Leucine and Lysine Is Reduced in Intrauterine Growth Restriction1 , 1998, Pediatric Research.

[168]  T. Powell,et al.  Intrauterine Growth Restriction Is Associated with a Reduced Activity of Placental Taurine Transporters , 1998, Pediatric Research.

[169]  M. Andrew,et al.  Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. , 1998, Thrombosis research.

[170]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[171]  M. Iwashita,et al.  Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. , 1998 .

[172]  P. Baker,et al.  Increased placental apoptosis in intrauterine growth restriction. , 1997, American journal of obstetrics and gynecology.

[173]  J. Harding,et al.  Antenatal therapy for intrauterine growth retardation , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[174]  C. Sibley,et al.  Association between the Activity of the System A Amino Acid Transporter in the Microvillous Plasma Membrane of the Human Placenta and Severity of Fetal Compromise in Intrauterine Growth Restriction , 1997, Pediatric Research.

[175]  J. Kingdom,et al.  Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. , 1997, Placenta.

[176]  C. Taylor,et al.  Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG, JAr and BeWo. , 1997, Placenta.

[177]  J. Kingdom,et al.  Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. , 1996, American journal of obstetrics and gynecology.

[178]  G. Greisen,et al.  Growth hormone, insulin‐like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery , 1996, Clinical endocrinology.

[179]  J. Kingdom,et al.  Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. , 1996, Placenta.

[180]  M. Whittle,et al.  Localisation of placenta growth factor (PIGF) in human term placenta. , 1996, Growth factors.

[181]  P. Karl.  Insulin‐like growth factor‐1 stimulates amino acid uptake by the cultured human placental trophoblast , 1995, Journal of cellular physiology.

[182]  J. Newnham,et al.  Screening for the Small Fetus: A Study of the Relative Efficacies of Ultrasound Biometry and Symphysiofundal Height , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.

[183]  X. Shu,et al.  Maternal Smoking, Alcohol Drinking, Caffeine Consumption, and Fetal Growth: Results from a Prospective Study , 1995, Epidemiology.

[184]  S. Gabbe,et al.  Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. , 1994, The Journal of reproductive medicine.

[185]  T. Jansson,et al.  Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. , 1993, The Journal of clinical endocrinology and metabolism.

[186]  C. Sibley,et al.  Amino Acid (System A) Transporter Activity in Microvillous Membrane Vesicles from the Placentas of Appropriate and Small for Gestational Age Babies , 1993, Pediatric Research.

[187]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[188]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[189]  A. Carter.  Current topic: restriction of placental and fetal growth in the guinea-pig. , 1993, Placenta.

[190]  R. Boys,et al.  Prediction Of The Small For Gestational Age Infant: Which Ultrasonic Measurement Is Best? , 1992, Obstetrics and gynecology.

[191]  K. Copeland,et al.  Secretion of prolactin and insulin-like growth factor I by decidual explant cultures from pregnancies complicated by intrauterine growth retardation. , 1992 .

[192]  G. Visser,et al.  The effects of maternal hyperoxia on fetal breathing movements, body movements and heart rate variation in growth retarded fetuses. , 1991, Early human development.

[193]  J. Kopelman,et al.  The Association of Antiphospholipid Antibodies With Pregnancies Complicated by Fetal Growth Restriction , 1991, Obstetrics and gynecology.

[194]  A. Avilés,et al.  Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children , 1991, American journal of hematology.

[195]  K. Maršál,et al.  Blood Velocity Waveforms in the Fetal Aorta and Umbilical Artery as Predictors of Fetal Outcome: A Comparison , 1991, American journal of perinatology.

[196]  T. Jansson,et al.  Placental Transfer of Glucose and Amino Acids in Intrauterine Growth Retardation: Studies with Substrate Analogs in the Awake Guinea Pig , 1990, Pediatric Research.

[197]  F. Cunningham,et al.  Chronic renal disease and pregnancy outcome , 1990, American journal of obstetrics and gynecology.

[198]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.

[199]  E. Mammen,et al.  Increased Intravascular Coagulation Associated With Pregnancy , 1990, Obstetrics and gynecology.

[200]  G. Pardi,et al.  Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. , 1990, American journal of obstetrics and gynecology.

[201]  K. Nicolaides,et al.  Plasma amino acids in appropriate- and small-for-gestational-age fetuses. , 1989 .

[202]  M. Khoury,et al.  Congenital malformations and intrauterine growth retardation: a population study. , 1988, Pediatrics.

[203]  K Marsál,et al.  Umbilical Artery and Uteroplacental Blood Flow Velocity Waveforms in Normal Pregnancy — A Cross‐Sectional Study , 1988, Acta obstetricia et gynecologica Scandinavica.

[204]  G. Kissling,et al.  Ultrasonic Recognition of the Small‐for‐Gestational‐Age Fetus , 1987, Obstetrics and gynecology.

[205]  S. Campbell,et al.  Routine Ultrasound Screening for Antenatal Detection of Intrauterine Growth Retardation , 1986, Obstetrics and gynecology.

[206]  A. Scott,et al.  Risk factors associated with small‐for‐dates and large‐for‐dates infants , 1985 .

[207]  H. Wilken,et al.  [Intraamniotic amino acid infusions in chronic placental insufficiency]. , 1977, Zentralblatt fur Gynakologie.

[208]  Wigglesworth Js.  Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. , 1974 .

[209]  R. Naeye,et al.  Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. , 1973, The Journal of pediatrics.